Want to join the conversation?
$NOC increased its guidance for 2016 diluted EPS to $10.75-11.00 to reflect YTD financial performance as well as an approx. $40MM or $0.20 per share tax benefit to be recorded in 3Q16. Sales are expected to be $23.5-24Bil in 2016. Capex is expected to be $0.8-1Bil and free cash flow is expected to be $1500-1800MM in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?